These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32828423)

  • 1. Dimeric small molecule agonists of EphA2 receptor inhibit glioblastoma cell growth.
    Orahoske CM; Li Y; Petty A; Salem FM; Hanna J; Zhang W; Su B; Wang B
    Bioorg Med Chem; 2020 Sep; 28(18):115656. PubMed ID: 32828423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of small molecule agonists of EphA2 receptor.
    Petty A; Idippily N; Bobba V; Geldenhuys WJ; Zhong B; Su B; Wang B
    Eur J Med Chem; 2018 Jan; 143():1261-1276. PubMed ID: 29128116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in vitro and prostate cancer metastasis in vivo.
    Petty A; Myshkin E; Qin H; Guo H; Miao H; Tochtrop GP; Hsieh JT; Page P; Liu L; Lindner DJ; Acharya C; MacKerell AD; Ficker E; Song J; Wang B
    PLoS One; 2012; 7(8):e42120. PubMed ID: 22916121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a new 1-(phenylsulfonyl)-1H-indole derivative targeting the EphA2 receptor with antiproliferative activity on U251 glioblastoma cell line.
    Guidetti L; Castelli R; Zappia A; Ferrari FR; Giorgio C; Barocelli E; Pagliaro L; Vento F; Roti G; Scalvini L; Vacondio F; Rivara S; Mor M; Lodola A; Tognolini M
    Eur J Med Chem; 2024 Oct; 276():116681. PubMed ID: 39024966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylinositol 3-Kinase/AKT Pathway Inhibition by Doxazosin Promotes Glioblastoma Cells Death, Upregulation of p53 and Triggers Low Neurotoxicity.
    Gaelzer MM; Coelho BP; de Quadros AH; Hoppe JB; Terra SR; Guerra MC; Usach V; Guma FC; Gonçalves CA; Setton-Avruj P; Battastini AM; Salbego CG
    PLoS One; 2016; 11(4):e0154612. PubMed ID: 27123999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine kinase activity of EphA2 promotes its S897 phosphorylation and glioblastoma cell proliferation.
    Hamaoka Y; Negishi M; Katoh H
    Biochem Biophys Res Commun; 2018 May; 499(4):920-926. PubMed ID: 29626472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EphA2 is a key effector of the MEK/ERK/RSK pathway regulating glioblastoma cell proliferation.
    Hamaoka Y; Negishi M; Katoh H
    Cell Signal; 2016 Aug; 28(8):937-45. PubMed ID: 27132626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Biological Evaluation of 1-(2-Aminophenyl)-3-arylurea Derivatives as Potential EphA2 and HDAC Dual Inhibitors.
    Zhu Y; Ran T; Chen X; Niu J; Zhao S; Lu T; Tang W
    Chem Pharm Bull (Tokyo); 2016; 64(8):1136-41. PubMed ID: 27477652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-Substituted quinazoline derivatives as novel EphA2 receptor tyrosine kinase inhibitors.
    Lim CJ; Oh KS; Ha JD; Lee JH; Seo HW; Chae CH; Kim DG; Lee MJ; Lee BH
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4080-3. PubMed ID: 25124116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of EphrinA2 receptors in postconditioning induced cardioprotection in rats.
    Kaur K; Singh N; Dhawan RK
    Eur J Pharmacol; 2020 Sep; 883():173231. PubMed ID: 32589885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of potent and selective cytotoxic activity of new quinazoline-ureas against TMZ-resistant glioblastoma multiforme (GBM).
    Elkamhawy A; Viswanath AN; Pae AN; Kim HY; Heo JC; Park WK; Lee CO; Yang H; Kim KH; Nam DH; Seol HJ; Cho H; Roh EJ
    Eur J Med Chem; 2015 Oct; 103():210-22. PubMed ID: 26355532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA interference targeting EphA2 inhibits proliferation, induces apoptosis, and cooperates with cytotoxic drugs in human glioma cells.
    Zhou Z; Yuan X; Li Z; Tu H; Li D; Qing J; Wang H; Zhang L
    Surg Neurol; 2008 Dec; 70(6):562-8; discussion 568-9. PubMed ID: 18614215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
    Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
    Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quantitative LC-MS/MS method for determination of a small molecule agonist of EphA2 in mouse plasma and brain tissue.
    Zhong B; Li Y; Idippily N; Petty A; Su B; Wang B
    Biomed Chromatogr; 2019 Apr; 33(4):e4461. PubMed ID: 30548501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of novel 1,3,4-thiadiazole derivatives as anti-glioblastoma agents targeting the AKT pathway.
    Szeliga M; Karpińska M; Rola R; Niewiadomy A
    Bioorg Chem; 2020 Dec; 105():104362. PubMed ID: 33074121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-Based Design of Novel EphA2 Agonistic Agents with Nanomolar Affinity in Vitro and in Cell.
    Gambini L; Salem AF; Udompholkul P; Tan XF; Baggio C; Shah N; Aronson A; Song J; Pellecchia M
    ACS Chem Biol; 2018 Sep; 13(9):2633-2644. PubMed ID: 30110533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective Tumor Targeting by EphA2-Agonist-Biotin-Streptavidin Conjugates.
    Udompholkul P; Baggio C; Gambini L; Sun Y; Zhao M; Hoffman RM; Pellecchia M
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34204178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationship analysis of peptides targeting the EphA2 receptor.
    Mitra S; Duggineni S; Koolpe M; Zhu X; Huang Z; Pasquale EB
    Biochemistry; 2010 Aug; 49(31):6687-95. PubMed ID: 20677833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering nanomolar peptide ligands that differentially modulate EphA2 receptor signaling.
    Gomez-Soler M; Petersen Gehring M; Lechtenberg BC; Zapata-Mercado E; Hristova K; Pasquale EB
    J Biol Chem; 2019 May; 294(22):8791-8805. PubMed ID: 31015204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of apoptosis in HL-1 cardiomyocytes by phosphorylation of the receptor tyrosine kinase EphA2 and protection by lithocholic acid.
    Jehle J; Staudacher I; Wiedmann F; Schweizer P; Becker R; Katus H; Thomas D
    Br J Pharmacol; 2012 Dec; 167(7):1563-72. PubMed ID: 22845314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.